Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12925
Title: 2-Arylbenzofurans from Artocarpus lakoocha and methyl ether analogs with potent cholinesterase inhibitory activity
Authors: Namdaung U.
Athipornchai A.
Khammee T.
Kuno M.
Suksamrarn S.
Keywords: 4 hydroxyartolakoochol
acetylcholinesterase
Artocarpus lakkocha extract
artolakoochol
benzofuran derivative
cholinesterase
cholinesterase inhibitor
cycloartolakoochol
dimethyl ether
flavonoid
galantamine
lakoochin
lakoochin A
plant extract
polycyclic aromatic hydrocarbon derivative
stilbenoid
unclassified drug
benzofuran derivative
cholinesterase inhibitor
ether derivative
Article
Artocarpus lakoocha
bark
bioassay
carbon nuclear magnetic resonance
cholinesterase inhibition
controlled study
drug binding site
drug isolation
drug potency
drug protein binding
drug screening
fractionation
heteronuclear multiple bond correlation
heteronuclear multiple quantum coherence
IC50
infrared spectroscopy
mass spectrometry
medicinal plant
molecular docking
nonhuman
nuclear Overhauser effect
plant root
proton nuclear magnetic resonance
structure activity relation
time of flight mass spectrometry
ultraviolet spectroscopy
Artocarpus
chemistry
metabolism
protein conformation
Acetylcholinesterase
Artocarpus
Benzofurans
Butyrylcholinesterase
Cholinesterase Inhibitors
Inhibitory Concentration 50
Methyl Ethers
Molecular Docking Simulation
Protein Conformation
Issue Date: 2018
Abstract: In vitro screening for acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities of the Artocarpus lakoocha root-bark extracts revealed interesting results. Bioassay-guided fractionation resulted in the isolation of two new (1 and 2) and six known 2-arylbenzofurans 3–8, along with one stilbenoid 9 and one flavonoid 10. The structures of the isolated compounds were elucidated by UV, IR, 1D- and 2D-NMR and MS spectroscopic data analysis. Compounds 4, 6 and 7 exhibited more potent AChE inhibitory activity (IC50 = 0.87–1.10 μM) than the reference drug, galantamine. Compounds 4, 8 and 9 displayed greater BChE inhibition than the standard drug. The preferential inhibition of BChE over AChE indicated that 4 also showed a promising dual AChE and BChE inhibitor. The synthetic mono-methylated analogs 4a-c and 6a-b were found to be good BChE inhibitors with IC50 values ranging between 0.31 and 1.11 μM. Based on the docking studies, compounds 4 and 6 are well-fitted in the catalytic triad of AChE. Compounds 4 and 6 showed different binding orientations on BChE, and the most potent BChE inhibitor 4 occupied dual binding to both CAS and PAS more efficiently. © 2017 Elsevier Masson SAS
URI: https://ir.swu.ac.th/jspui/handle/123456789/12925
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032904600&doi=10.1016%2fj.ejmech.2017.10.019&partnerID=40&md5=432c2cf8bca660fe707701579f177bf7
ISSN: 2235234
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.